TP53 and cancer: Thus, p53-inhibitory TRIM members, including TRIM23 [38,39,40], TRIM24 [41,42,43], TRIM25 [44,45], TRIM28 [46,47], TRIM29 [48,49], and TRIM59 [50,51], are frequently overexpressed in human cancers.